## XPEV: XPeng Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -11.1% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: declining volume (44% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($17.05)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 5 |

**Top Holders:**
- Alibaba Group Holdin: 4.3% (0.0%)
- TMT General Partner : 3.3% (-0.4%)
- Primecap Management : 1.8% (-3.7%)
- UBS Group AG: 1.3% (+23.8%)
- Marshall Wace LLP: 0.7% (+244.3%)

### Key Risks

1. Long-term trend broken: trading 7.4% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.36 indicates undervaluation relative to growth. Revenue growth strong at 42% YoY. Institutional flow bullish (3 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.8B |
| Beta | 1.05 |
| 52W Range | $11.14 - $28.23 |
| Short Interest | 4.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.36 |
| Forward P/E | 7.3 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from -12.5% to -11.1% (+1.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 15.1pp (needs >4.0% for momentum thesis). AM_20 at -9.1% indicates price below own 20MA trend. Underperforming sector by 12.0pp, stock-specific weakness. Below SMA200 (0.93x), long-term trend not supportive. Volume at 44% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -11.10% (CS: 0) | Weak |
| RSI_14 | 39.9 | Neutral |
| MACD Histogram | -0.16 | Bearish |
| vs SMA20 | 0.909x | Below |
| vs SMA50 | 0.864x | Below |
| vs SMA200 | 0.926x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $19.19
- **Stop Loss:** $17.05 (11.2% risk)
- **Target:** $21.33 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 644
- **Position Value:** $12,358.36
- **Portfolio %:** 12.36%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-03-17 (Est: $0.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.47 | $-0.16 | +65.8% |
| 2025Q2 | $-1.06 | $-0.41 | +61.4% |
| 2025Q1 | $-1.51 | $-0.45 | +70.2% |
| 2024Q4 | $-1.45 | $-1.47 | -1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*